Trial intelligence / Profile preview

Gabapentin Premedication for PONV in Spinal Morphine Patients

NCT02944981Phase 4Completed

Sponsor
Khon Kaen University
Start
Aug 2016
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Gabapentin with Placebo (2 arms). Primary endpoint: Postoperative nausea and vomiting at 24 hours. Started Aug 2016; status: completed.

02

Drugs

gabapentin
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT02944981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02944981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call